Clinical usefulness of serum ferritin level in patients with fatty liver | ||
| Minia Journal of Medical Research | ||
| Volume 31, Issue 2, April 2020, Pages 201-205 PDF (191.17 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjmr.2022.221015 | ||
| Authors | ||
| Ehab Mohammed1; Lamia Hamdy2; Yasser Ahmed1; Norhan Ali1 | ||
| 1Department of Tropical Medicine, Minia University | ||
| 2Department of clinical pathology, Minia University. | ||
| Abstract | ||
| Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease worldwide. Recently several parameters, such as serum ferritin, have emerged as possible predictors for the severity of NAFLD and insulin sensitivity. We aimed to investigate the value of serum ferritin level as a useful biomarker for the prediction of disease severity in patients with NAFLD. Methods: This was a prospective cross sectional study in which demographic, clinical and laboratory data of 101 adult patients with NAFLD were analyzed. Results: In our patients population with mean age of 49.2 years and mean BMI of 31.9, it was also observed that ferritin level did not have a significant correlation with the stage of fibrosis (p = 0.835). Conclusion: Hyperferritinemia is common in patients with NAFLD but the extent of serum ferritin elevations do not predict the stage of underlying NAFLD disease. | ||
| Keywords | ||
| Ferritin; Non-alcoholic Fatty Liver Disease; Hepatic steatosis score. | ||
|
Supplementary Files
|
||
|
Statistics Article View: 75 PDF Download: 637 |
||
